Stephen L Sabba - Net Worth and Insider Trading
Stephen L Sabba Net Worth
The estimated net worth of Stephen L Sabba is at least $4 Million dollars as of 2024-11-09. Stephen L Sabba is the Director of Ligand Pharmaceuticals Inc and owns about 28,926 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $4 Million. Details can be seen in Stephen L Sabba's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen L Sabba has not made any transactions after 2024-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen L Sabba
Stephen L Sabba Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen L Sabba owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Novelion Therapeutics Inc (NVLNF) .
Click here to see the complete history of Stephen L Sabba’s form 4 insider trades.
Insider Ownership Summary of Stephen L Sabba
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-03-05 | director |
| NVLNF | Novelion Therapeutics Inc | 2018-08-09 | director |
Stephen L Sabba Latest Holdings Summary
Stephen L Sabba currently owns a total of 1 stock. Stephen L Sabba owns 28,926 shares of Ligand Pharmaceuticals Inc (LGND) as of March 5, 2024, with a value of $4 Million.
Latest Holdings of Stephen L Sabba
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-03-05 | 28,926 | 121.19 | 3,505,542 |
Holding Weightings of Stephen L Sabba
Stephen L Sabba Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen L Sabba has made a total of 3 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 1,893 shares on March 5, 2024, which brought Stephen L Sabba around $140,650.
Insider Trading History of Stephen L Sabba
- 1
Stephen L Sabba Trading Performance
GuruFocus tracks the stock performance after each of Stephen L Sabba's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen L Sabba is 31.7%. GuruFocus also compares Stephen L Sabba's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen L Sabba within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen L Sabba's insider trading performs compared to the benchmark.
Performance of Stephen L Sabba
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.72 | | | | | |
| Relative Return to S&P 500(%) | 11.62 | | | | | |
Stephen L Sabba Ownership Network
Ownership Network List of Stephen L Sabba
Ownership Network Relation of Stephen L Sabba
Stephen L Sabba Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Stephen L Sabba is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Stephen L Sabba made 2 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 8,301. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 112,635 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 106,135 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Stephen L Sabba Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen L Sabba. You might contact Stephen L Sabba via mailing address: Dorset Management Corp, 485 Underhill Blvd Suite 205, Syosset Ny 11791.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
